Pathobiology of Troponin Elevations
Author:
- Harvey D. WhiteHWHarvey D. White
Abstract
No abstract availableFunding Information
- Sanofi-Aventis
- Eli Lilly and Company
- The Medicines Company
- National Institutes of Health
- Pfizer
- Roche
- Johnson & Johnson
- Schering-Plough
- Merck Sharp & Dohme
- GlaxoSmithKline
- Daichii Sankyo Pharma Development
- Bristol-Myers Squibb
This publication has 27 references indexed in Scilit:
- Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive AssayJACC, 2011
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: Observations from the PROTECT-TIMI 30 TrialAmerican Heart Journal, 2009
- Evidence for Cardiomyocyte Renewal in HumansScience, 2009
- Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical PracticeClinical Chemistry, 2009
- Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35European Heart Journal, 2008
- Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary SyndromeClinical Chemistry, 2008
- Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulationPflügers Archiv - European Journal of Physiology, 2007
- Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteriesInternational Journal of Cardiology, 2005
- Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarctionThe American Journal of Cardiology, 1991